A detailed history of Numerai Gp LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Numerai Gp LLC holds 56,766 shares of PRCT stock, worth $4.61 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares
56,766
Previous 59,449 4.51%
Holding current value
$4.61 Million
Previous $3.63 Billion 25.23%
% of portfolio
1.21%
Previous 1.32%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$56.31 - $84.99 $151,079 - $228,028
-2,683 Reduced 4.51%
56,766 $4.55 Billion
Q2 2024

Aug 14, 2024

BUY
$45.73 - $69.19 $311,284 - $470,976
6,807 Added 12.93%
59,449 $3.63 Billion
Q1 2024

May 15, 2024

BUY
$40.38 - $50.75 $1.91 Million - $2.4 Million
47,194 Added 866.26%
52,642 $2.6 Billion
Q4 2023

Feb 14, 2024

BUY
$24.89 - $43.41 $135,600 - $236,497
5,448 New
5,448 $228 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.62B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Numerai Gp LLC Portfolio

Follow Numerai Gp LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Numerai Gp LLC, based on Form 13F filings with the SEC.

News

Stay updated on Numerai Gp LLC with notifications on news.